WallStSmart

Dynex Capital Inc (DX)vsWelltower Inc (WELL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 3771% more annual revenue ($11.77B vs $303.96M). DX leads profitability with a 79.5% profit margin vs 12.0%. DX appears more attractively valued with a PEG of 0.71. DX earns a higher WallStSmart Score of 77/100 (B+).

DX

Strong Buy

77

out of 100

Grade: B+

Growth: 8.3Profit: 7.5Value: 9.3Quality: 2.5
Piotroski: 2/9Altman Z: -0.72

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 3.0Quality: 7.0
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DXUndervalued (+55.9%)

Margin of Safety

+55.9%

Fair Value

$31.65

Current Price

$13.18

$18.47 discount

UndervaluedFair: $31.65Overvalued

Intrinsic value data unavailable for WELL.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DX6 strengths · Avg: 10.0/10
P/E RatioValuation
6.2x10/10

Attractively priced relative to earnings

Price/BookValuation
1.0x10/10

Reasonable price relative to book value

Profit MarginProfitability
79.5%10/10

Keeps 80 of every $100 in revenue as profit

Operating MarginProfitability
136.0%10/10

Strong operational efficiency at 136.0%

Revenue GrowthGrowth
234.8%10/10

Revenue surging 234.8% year-over-year

EPS GrowthGrowth
92.3%10/10

Earnings expanding 92.3% YoY

WELL3 strengths · Avg: 9.7/10
Revenue GrowthGrowth
38.3%10/10

Revenue surging 38.3% year-over-year

EPS GrowthGrowth
157.9%10/10

Earnings expanding 157.9% YoY

Market CapQuality
$160.48B9/10

Large-cap with strong market position

Areas to Watch

DX3 concerns · Avg: 2.0/10
Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Altman Z-ScoreHealth
-0.722/10

Distress zone — elevated risk

Debt/EquityHealth
7.731/10

Elevated debt levels

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
3.2%3/10

ROE of 3.2% — below average capital efficiency

PEG RatioValuation
3.622/10

Expensive relative to growth rate

P/E RatioValuation
109.8x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : DX

The strongest argument for DX centers on P/E Ratio, Price/Book, Profit Margin. Profitability is solid with margins at 79.5% and operating margin at 136.0%. Revenue growth of 234.8% demonstrates continued momentum.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, EPS Growth, Market Cap. Revenue growth of 38.3% demonstrates continued momentum.

Bear Case : DX

The primary concerns for DX are Piotroski F-Score, Altman Z-Score, Debt/Equity. Debt-to-equity of 7.73 is elevated, increasing financial risk.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 109.8x leaves little room for execution misses.

Key Dynamics to Monitor

DX carries more volatility with a beta of 0.93 — expect wider price swings.

DX is growing revenue faster at 234.8% — sustainability is the question.

WELL generates stronger free cash flow (282M), providing more financial flexibility.

Monitor REIT - MORTGAGE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

DX scores higher overall (77/100 vs 57/100), backed by strong 79.5% margins and 234.8% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Dynex Capital Inc

REAL ESTATE · REIT - MORTGAGE · USA

Dynex Capital, Inc., a mortgage real estate investment trust, invests in Mortgage-Backed Securities (MBS) on a leveraged basis in the United States. The company is headquartered in Glen Allen, Virginia.

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?